The 2021 year in endocrinology, diabetology, and metabolic diseases saw the arrival of new medical treatments, notably for Cushing's syndrome and hypercholesterolemia, in addition to the revival of treatments that were already known, yet without finding their correct place within our therapeutic arsenal.
All these treatments were likely promising, because of being effective and well tolerated. Although some of them are not yet available in Belgium, we thought it useful to actually discuss them, as they well illustrate the continuing dynamism of clinical research within this sector, whereas our activities have been somewhat thwarted by the current pandemic. We sincerely hope you enjoy the reading!
Thyroid gland, thermoablation, Cushing's syndrome, cortisol, steroidogenesis inhibitor, bempedoic acid, cholesterol, eztimibe, statin, obesity, metabolic syndrome, dietary intervention